Verition Fund Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,942
Closed -$1.89M 3433
2025
Q4
$1.89M Buy
38,942
+33,236
+582% +$1.65M 0.01% 1659
2025
Q3
$269K Buy
+5,706
New +$275K ﹤0.01% 3347
2025
Q2
Sell
-29,306
Closed -$1.63M 3845
2025
Q1
$1.63M Buy
+29,306
New +$1.59M 0.01% 1727
2024
Q3
Sell
-12,213
Closed -$593K 3492
2024
Q2
$593K Buy
+12,213
New +$589K ﹤0.01% 1965
2015
Q1
Sell
-38,489
Closed -$1.75M 492
2014
Q4
$1.75M Buy
+38,489
New +$1.87M 0.39% 37
2013
Q4
Sell
-11,789
Closed -$597K 652
2013
Q3
$597K Buy
+11,789
New +$600K 0.09% 179

Other funds holding SNY

Verition Fund Management's SNY Position: Q1 2026 in Review

Verition Fund Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 38,942 shares — an estimated $1.89M sold.

Verition Fund Management first reported a position in SNY in Q3 2013 and held it in 6 quarters. The position peaked at $1.89M in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Verition Fund Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 38,942 Sanofi shares in Q1 2026, an estimated $1.89M.
  • Verition Fund Management first reported a position in Sanofi in Q3 2013 and held it in 6 quarters.
  • Verition Fund Management's Sanofi position peaked at $1.89M in Q4 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.